Publication:
Fetal Warfarin syndrome

dc.contributor.authorAchara Sathienkijkanchaien_US
dc.contributor.authorPornswan Wasanten_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-06-21T08:24:30Z
dc.date.available2018-06-21T08:24:30Z
dc.date.issued2005-08-01en_US
dc.description.abstractFetuses exposed to Warfarin in the first trimester of pregnancy have an increased risk of embryopathy which consists of nasal hypoplasia and stippled epiphyses, known as fetal warfarin syndrome or warfarin embryopathy. We herein report a first case of an infant with fetal warfarin syndrome in Thailand. The patient was an offspring of a 34-year-old mother with history of SLE and arterial embolism for several years. She had an unplanned pregnancy while taking warfarin. The patient developed difficulty breathing in the first few hours after birth from severe nasal hypoplasia. He also had short limbs, brachydactyly, nail hypoplasia, and calcifications in the epiphyseal regions of humeri, femora and vertebrae radiographically. The patient eventually died from respiratory failure at 6 months of age.en_US
dc.identifier.citationJournal of the Medical Association of Thailand. Vol.88, No.SUPPL. 8 (2005)en_US
dc.identifier.issn01252208en_US
dc.identifier.issn01252208en_US
dc.identifier.other2-s2.0-31744447279en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/16871
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=31744447279&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleFetal Warfarin syndromeen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=31744447279&origin=inwarden_US

Files

Collections